North America Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Dosage, Disease, and Technology

Liquid Vaccines Segment to Dominate North America Poultry Vaccines Market During 2021-2028

According to a new market research study on “North America Poultry Vaccines Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Dosage, Disease, and Technology” is expected to reach US$ 1,449.99 million by 2028 from US$ 901.74 million in 2021. The market is estimated to grow at a CAGR of 7% from 2021 to 2028. The report provides trends prevailing in the North America poultry vaccines market along with the drivers and restraints pertaining to the market growth. Growing prevalence of diseases in poultry and rising demand for healthy poultry food are the major factor driving the growth of the North America poultry vaccines market. However, inactivation of the vaccine after vaccination and errors related to managemental, technicalities in poultry vaccines hinders the growth of North America poultry vaccines market.

In case of COVID-19, North America is highly affected specially the US. The incidence of corona virus or COVID 19 has not yet been registered the animals. Also, there is no evidence that poultry birds are the prime source of the spreading epidemic in humans. However, various studies have been conducted to check the spread of disease from animals to humans. In many cases, zoonotic diseases were found in humans due to interaction with animals. Therefore, government bodies are taking more precautions and safety measures to prevent the spread of corona virus in the animals. The measures are widely carried out for companion animals as they frequently come in contact with their owners. Also, it is essential to report the cases to a veterinary authority. For instance, in the region, to report the cases of detection of COVID-19 is done to OIE through WAHIS, in accordance with the OIE Terrestrial Animal Health Code as an emerging disease. The COVID-19 pandemic and the associated lockdown for a long period have created a significant adverse impact on different sectors, including that of the agriculture and other allied sub-sectors in India and several other countries. The OIE is actively working by aiding research for their on-going research and other implications of COVID-19 for animal health and poultry public health. The assistance is also providing risk assessment, risk management, and risk communication.

The North America poultry vaccines market has been segmented into the dosage, disease, technology, and country. Based on dosage, market has been segmented into the duct vaccines, liquid vaccines, and freeze-dried vaccines. The liquid vaccines segment dominated the North America poultry vaccines market in 2020 and is also expected to be fastest growing during forecast period. Based on disease, market has been segmented into infectious bronchitis, avian influenza, Marek’s disease, Newcastle disease, and others. The infectious bronchitis segment dominated the North America poultry vaccines market in 2020 and avian influenza segment is expected to be fastest growing during forecast period. Based on technology, market has been segmented into toxoid vaccines, recombinant vaccines, inactivated vaccines, live attenuated vaccines, and others. The live attenuated vaccines segment dominated the North America poultry vaccines market in 2020 and recombinant vaccines segment is expected to be fastest growing during forecast period.

Boehringer Ingelheim International GmbH; CEVA; Merck & Co. Inc.; PHIBRO POULTRY VACCINES CORPORATION; Virbac; and Zoetis Inc. are among the leading companies in the North America poultry vaccines market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Boehringer Ingelheim, a global leader in animal health, announced the launch of Prevexxion RN and Prevexxion RN+HVT+IBD, the next generation of Marek’s disease vaccines, in the European Union countries and the United Kingdom.

The report segments the North America Poultry Vaccines Market as follows:

North America Poultry Vaccines Market - By Dosage

• Duct Vaccines
• Liquid Vaccines
• Freeze-Dried Vaccines

North America Poultry Vaccines Market - By Disease

• Infectious Bronchitis
• Avian Influenza
• Marek’s Disease
• Newcastle Disease
• Others

North America Poultry Vaccines Market - By Technology

• Toxoid Vaccines
• Recombinant Vaccines
• Inactivated Vaccines
• Live Attenuated Vaccines
• Others

North America Poultry Vaccines Market - By Country

• US
• Canada
• Mexico

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America poultry vaccines market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in North America poultry vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the poultry vaccines market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution